Secondary Prevention Treatment in Patients Who Have Suffered a Cardiovascular Event
NCT01395550 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 88
Last updated 2011-08-30
Summary
AstraZeneca was interested in knowing how Cardiologists and Physicians treat patients who have suffered a cardiovascular event.
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-01-31
- Primary Completion
- 2010-07-31
- Completion
- 2010-07-31
More Related Trials
-
Hirudin Plus Aspirin in the Secondary Prevention of Cardioembolic Stroke Due to Nonvalvular Atrial Fibrillation
NCT02181361 ·Status: COMPLETED
-
Direct Oral Anticoagulants in Patients With Atrial Fibrillation (DOACs vs DOACs)
NCT03568916 ·Status: COMPLETED
-
Aspirin Response in High Risk Patients With Coronary Artery Disease
NCT01383304 ·Status: UNKNOWN
-
Long-term Follow-up of antithrombotIc Management Patterns in Acute Coronary Syndrome Patients in Asia-China Extension
NCT02305680 ·Status: COMPLETED
-
Women With Chest Pain and Normal Coronary Arteries Study
NCT00743197 ·Status: TERMINATED ·Phase: NA
-
Long-tErm Follow-uP of antithrombotIc Management Patterns In Acute CORonary Syndrome Patients in Asia
NCT01361386 ·Status: COMPLETED
-
Pharmacodynamic Effects of Dabigatran in Patients on Dual Antiplatelet Therapy
NCT01852162 ·Status: COMPLETED ·Phase: NA
-
Ticagrelor Antiplatelet Therapy to Reduce Graft Events and Thrombosis
NCT02053909 ·Status: COMPLETED ·Phase: PHASE4
-
Optimized Antiplatelet Therapy on the Prognosis of ACS Patients With Non-predominant Coronary Artery Disease After PCI
NCT04338919 ·Status: UNKNOWN ·Phase: NA
-
Burden of Ischemic Stroke and Intake of Oral Anticoagulants in Patients With Atrial Fibrillation in the UK Primary Care
NCT04099238 ·Status: COMPLETED
-
Outcomes in UK ACS Patients Prescribed Ticagrelor
NCT03058601 ·Status: COMPLETED
-
Correlation of Endothelial Function and Early Coronary Artery Disease in Humans
NCT00271492 ·Status: COMPLETED ·Phase: PHASE3
-
Platelet-Inhibitor Drug Trial in Coronary Angioplasty
NCT00000510 ·Status: COMPLETED ·Phase: PHASE3
-
Antiplatlet Effects of Standardized Tomato Extract in Hypertensive Subjects
NCT03206944 ·Status: COMPLETED ·Phase: PHASE4
-
Direct Oral Anticoagulants in Patients with Atrial Fibrillation (DOACs Vs Warfarin)
NCT03596502 ·Status: COMPLETED
-
Heart Outcomes Prevention Evaluation-3
NCT00468923 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Low Dose Colchicine and Ticagrelor in Prevention of Ischemic Stroke in Patients With Stroke Due to Atherosclerosis
NCT05476991 ·Status: RECRUITING ·Phase: PHASE3
-
Aspirin to Target Arterial Events in Chronic Kidney Disease
NCT03796156 ·Status: TERMINATED ·Phase: PHASE3
-
PPARGC1β and CNTN4 Genotype Aspirin Study
NCT02970604 ·Status: UNKNOWN ·Phase: PHASE4
-
Aspirin Withdrawal and Clinical Outcome in Patients With Moderate to High Cardiovascular Risk But Without Cardiovascular Disease
NCT03757156 ·Status: UNKNOWN ·Phase: NA
-
Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Prolonged DAPT Regimen
NCT03023020 ·Status: COMPLETED ·Phase: NA
-
Thromboxane Receptor Antagonist to Improve Endothelial Function
NCT03962855 ·Status: COMPLETED ·Phase: PHASE2
-
Resistance on Antithrombotic Drugs in Ischemic Heart Disease
NCT00742430 ·Status: COMPLETED
-
Reversing Ticagrelor's Effects With Fresh Platelets
NCT02201394 ·Status: COMPLETED ·Phase: PHASE4
-
Recurrent Carotid Stenosis
NCT00000527 ·Status: COMPLETED ·Phase: PHASE2